With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To realize this potential, adMare uses its scientific and commercial expertise, specialized R&D infrastructure, and investment capital to build investable companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term.
Our 25+ portfolio companies have attracted more than $1.4 billion of investment, have a combined value of over $3 billion, and employ more than 900 Canadians. Our Montreal and Vancouver Innovation Centres are home to ~35 biotech companies (ranging from highly-promising start-ups to industry leaders), contract research organizations and specialized commercialization support service organizations. The adMare Academy has trained more than 500 alumni – 95% of whom are employed in the Canadian life sciences industry.
BioTalent Canada™ is the HR partner of and a catalyst for growth in Canada’s bio-economy. Our engagement with employers, associations, post-secondary institutions, immigrant serving agencies and service providers has built a dynamic network that is strengthening skills, connecting job-ready talent to industry and creating opportunities.
Created in 1983, the Fonds de solidarité FTQ is a development capital fund that calls upon the solidarity and savings of Quebecers to help fulfill its mission to contribute to Québec’s economic growth by creating, maintain or protecting jobs through investments in small and medium-sized businesses in all spheres of activity. The Fonds also seeks to encourage Quebecers to save for retirement and to offer its over half a million shareholders-savers a reasonable return over and above the outstanding tax benefits they receive by purchasing Fonds shares. https://www.fondsftq.com/en
Genome Canada is a not-for-profit organization, funded by the Government of Canada. We act as a catalyst for developing and applying genomics+ and genomic-based technologies to create economic and social benefits for Canadians. We: connect ideas and people across public and private sectors to find new uses for genomics, invest in large-scale science and technology to fuel innovation; and, translate discoveries into solutions across key sectors of national importance, including health, agriculture and agri-food, forestry, fisheries and aquaculture, the environment, energy and mining.
About Roche Canada
Patients and science are at the heart of everything we do. At Roche, our passion for science and our commitment to relentlessly pursuing the impossible for patients has made us one of the world’s leading pharmaceutical, in vitro diagnostics, and healthcare technology companies. And we’re adding our expertise in new areas, such as artificial intelligence, real world data collection and analysis and collaborating with many different sectors and industries. We’re an innovator across major disease areas, including oncology, infectious diseases, diabetes, ophthalmology, and diseases of the central nervous system.
Roche Canada was founded in 1931 and employs more than 1,800 people across the country through its Pharmaceuticals division in Mississauga, Ontario as well as its Diagnostics and Diabetes Care divisions in Laval, Quebec.
For more information, please visit www.RocheCanada.com or follow us on Twitter @RocheCanada.